|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8396 USD | -0.53% |
|
+0.96% | -26.35% |
| 20/07 | Iridex Augments EyeProGPO Product Offering With EndoProbe Handpieces | MT |
| 14/07 | Novel Inspiration International Co Ltd Intends to Engage with IRIDEX Corporation | CI |
Company Valuation: IRIDEX Corporation
Data adjusted to current consolidation scope
| Fiscal Period: January | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 101.9 | 32.94 | 45.17 | 29.45 | 20.11 | 14.69 | - | - |
| Change | - | -67.66% | 37.12% | -34.81% | -31.7% | -26.95% | - | - |
| Enterprise Value (EV) | 101.9 | 32.94 | 45.17 | 29.45 | 20.11 | 14.69 | 14.69 | 14.69 |
| Change | - | -67.66% | 37.12% | -34.81% | -31.7% | -26.95% | 0% | 0% |
| P/E | -18.9x | -4.38x | -4.71x | -3.28x | -4.5x | -16.9x | 42.2x | 12.1x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0.1x | -0.2x | 0.39x | 0.1x | 0.2x | -0x | 0x |
| Capitalization / Revenue | 1.89x | 0.58x | 0.87x | - | 0.38x | 0.28x | 0.26x | 0.24x |
| EV / Revenue | 0x | 0x | 0x | - | 0x | 0.28x | 0.26x | 0.24x |
| EV / EBITDA | -0x | -0x | -0x | - | 0x | 5.98x | 4.04x | 3.22x |
| EV / EBIT | -0x | -0x | -0x | - | -0x | -55.4x | 18.3x | 8.46x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.34 | -0.47 | -0.59 | -0.54 | -0.26 | -0.05 | 0.02 | 0.07 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 53.9 | 56.97 | 51.87 | - | 52.68 | 53 | 56.77 | 60.09 |
| EBITDA 1 | -6.73 | -7.057 | -7.259 | - | 1.122 | 2.457 | 3.641 | 4.559 |
| EBIT 1 | -7.533 | -7.542 | -10.01 | - | -2.571 | -0.265 | 0.801 | 1.737 |
| Net income 1 | -5.225 | -7.547 | -9.57 | -8.91 | -4.437 | -0.795 | 0.361 | 1.383 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 6.4200 | 2.0601 | 2.7800 | 1.7700 | 1.1700 | 0.8441 | 0.8441 | 0.8441 |
| Nbr of stocks (in thousands) | 15,866 | 15,990 | 16,248 | 16,636 | 17,190 | 17,407 | - | - |
| Announcement Date | 10/3/22 | 9/3/23 | 26/3/24 | 27/3/25 | 26/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -16.88x | - | - | - | 14.69M | |
| 28.78x | 5.13x | 19.66x | 0.32% | 214B | |
| 33.46x | 6.09x | 19.3x | 0.73% | 140B | |
| 41.17x | 10.7x | 23.66x | -.--% | 133B | |
| 17.85x | 3.65x | 11.84x | -.--% | 69.19B | |
| 35.16x | 7.07x | 22.36x | -.--% | 51.28B | |
| 19.81x | 2.31x | 11.7x | 2.58% | 50.43B | |
| 27.44x | 5.45x | 18.64x | 0.73% | 39.85B | |
| 71.82x | 6.66x | 20.08x | -.--% | 39.27B | |
| 21.15x | 5.57x | 14.3x | 1.09% | 32.32B | |
| Average | 27.98x | 5.85x | 17.95x | 0.61% | 76.89B | |
| Weighted average by Cap. | 32.43x | 6.19x | 18.98x | 0.47% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IRIX Stock
- Valuation IRIDEX Corporation
Select your edition
All financial news and data tailored to specific country editions
